Key result
Non-mid-range QTc linked to ~61% higher 14-day mortality in patients with sepsis.
Why the study?
Objective markers for dismal prognosis in patients suffering from sepsis are sought, including the potential role of corrected QT interval anomalies.
Does non-mid-range QTc duration predict increased mortality in septic patients?
Cohort (n=257)
Does non-mid-range QTc duration predict increased mortality in septic patients?
QTc duration anomalies (both short and long) are associated with significantly higher short- and medium-term mortality in patients with sepsis.
Answers are grounded in this paper and cite their sources.
QTc anomalies may flag higher sepsis mortality risk; leaves open incremental prognostic value beyond standard scores.
BACKGROUND: Patients suffering from sepsis experience organ failure and metabolic derangements, with a negative impact on their prognosis and survival. Objective markers for dismal prognosis in this group of patients are sought. AIMS: To assess the potential role of corrected QT interval anomalies as surrogates for metabolic derangements leading to increased short and medium-term mortality in patients suffering from sepsis. METHODS: This study utilised a historic-cohort analysis of 257 septic patients admitted to internal medicine departments. Personal data, vital signs, laboratory results and electrocardiograms were collected. Patients were grouped according to QTc duration, weather mid-range (395-490 ms) or non-mid-range, and further defined as shorter (<395 ms) or longer (>490 ms). RESULTS: Mortality rates differed significantly between the mid-range QTc group and the non-mid-range groups at 14 days (23.7 vs 38.2%, respectively; P = 0.014) and at 3 months (38.5 vs 59.6%, respectively; P = 0.001). In a three-group analysis, the 14-day mortality was the highest in the longer QTc group and the lowest in the mid-range group compared with the shorter QTc group (44.4, 23.7 and 35.5%, respectively; P = 0.034), and this difference also remained at 3 months (74.1, 38.5 and 53.2%, respectively; P = 0.001). All differences remained statistically significant in a multivariate Cox regression analysis. CONCLUSIONS: QTc duration anomalies are associated with worse short- and medium-term prognosis and may act as a marker for more severe clinical sequelae.
No takes yet. Share an insight, caveat, or question.
Wasserstrum et al. (2016) conducted a cohort in Sepsis (n=257). Non-mid-range QTc duration (<395 ms or >490 ms) vs. Mid-range QTc duration (395-490 ms) was evaluated on 14-day mortality (p=0.014). Non-mid-range QTc duration was associated with significantly higher 14-day mortality compared to mid-range QTc (38.2% vs 23.7%; P=0.014) in patients with sepsis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: